We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Eidogen-Sertanty Licenses Target Informatics Platform to AstraZeneca
News   Dec 16, 2005

Scientists at AstraZeneca will access Eidogen-Sertanty’s tools to assist drug discovery efforts.

READ MORE

CytRx Enters Into Licensing Agreement with the UMMS
News   Dec 16, 2005

CytRx has identified drug targets using RNAi screening technology through the existing collaborative program.

READ MORE

3DNA Array Detection
News   Dec 16, 2005

Genisphere has entered into an agreement with Invitrogen under which Invitrogen will become the exclusive provider of miRNA microarray labeling kits using Genisphere 3DNA technology.

READ MORE

Sage-N Research Expands Into China with New R&D Center for Proteomics
News   Dec 15, 2005

The Sage-N Shanghai Center will work closely with leading proteomics scientists to quickly incorporate new technologies.

READ MORE

Roche and SystemsX Collaborate in Diabetes Research
News   Dec 15, 2005

The partnership will translate systems biology research into improved medicines.

READ MORE

Imperial, MRC and Affymetrix Collaborate to Speed-up Therapy Development
News   Dec 15, 2005

The alliance will enable the partners to undertake the larger research programmes needed to produce medical applications.

READ MORE

Personalizing the Management of Breast Cancer
News   Dec 15, 2005

Researchers are using SNPs to see how genetic variability affects how people respond to chemotherapy drugs.

READ MORE

Maxygen Announces Achievement of Milestone in Roche Alliance
News   Dec 15, 2005

Maxygen achieves this milestone to develop improved interferon alpha protein therapeutics.

READ MORE

InforSense Expands Ongoing Collaboration with AstraZeneca
News   Dec 15, 2005

AstraZeneca scientists will use InforSense KDE to enhance drug discovery decision-making.

READ MORE

Eidogen-Sertanty and Kalypsys Establish Drug Discovery Collaboration
News   Dec 15, 2005

Eidogen-Sertanty will utilize Kalypsys’ DirectDesign™ computational drug discovery platform to design a virtual library of drug-like compounds.

READ MORE